介质干细胞在帕金森病中的潜在作用
Pratima Tambe1, Vaishali Undale1, Avinash Sanap2
1Department of Pharmacology, Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research, Pimpri, Pune, 411018, India.
Parkinsonism & related disorders
|August 14, 2024
概括
介质干细胞 (MSC) 疗法通过提供神经保护和再生,对帕金森病 (PD) 显示出前景. 本综述探讨了MSC及其衍生品作为PD的潜在治疗方法,解决当前的挑战.
科学领域:
- 神经科学是一个神经科学.
- 再生医学是一种再生医学.
- 细胞疗法细胞疗法
背景情况:
- 帕金森病 (PD) 是一种神经退行性疾病,具有显著的运动和认知影响.
- 目前的PD治疗是症状性的,并没有解决潜在的疾病机制.
- 对于帕金森病的新型治疗策略有着至关重要的需求.
研究的目的:
- 对帕金森病中介质干细胞 (MSC) 治疗的临床前和临床证据进行审查.
- 探索MSCs在PD中的神经保护,抗炎和再生潜力.
- 讨论MSC衍生物的应用,如秘密体和外生体,在PD管理中.
主要方法:
- 对现有的科学文献进行全面的审查.
- 对PD的MSC进行临床前研究的分析.
- 对临床试验数据的评估,关于基于MSC的PD治疗方法.
主要成果:
- MSCs具有与PD相关的神经保护性,抗炎性和再生性.
- MSC衍生物 (秘密体,外体) 也显示出治疗潜力.
- 有证据表明,MSC疗法可以为帕金森病提供一种疾病修饰方法.
结论:
- 介质细胞干细胞疗法为帕金森病管理提供了一个有前途的途径.
- 需要进一步的研究,以克服临床应用的交付,时间和安全性方面的挑战.
- 基于MSC的策略,包括衍生品,为改善帕金森病治疗提供了希望.
相关概念视频
Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
Parkinson's Disease: Overview
501
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
501
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Parkinson's Disease: Treatment
240
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
240
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Induced Pluripotent Stem Cells
22.0K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
22.0K


